22.84 -0.63 (-2.72%)
XNPT
Stock Details
Last Trade:22.84 Change:-0.63 (-2.72%) Prev Close:23.47 Open: 23.14 Days Range:22.07 – 23.74 52 Week Range: 13.36 - 51.42 Volume:245281 P/E: N/AEPS:-2.29
View AllRecent Alerts 07/04/09
Recent Alert on 07/01/09 at 9:42am
Piper Jaffray Maintains an Overweight on XenoPort (XNPT); Price Target Increased
Piper Jaffray Maintains an Overweight on XenoPort (XNPT); Price Target Increased
Piper Jaffray & Co. maintains an Overweight rating on XenoPort (Nasdaq: XNPT), price target increased from $26 to $30. Piper analyst says, "Yesterday, XenoPort reported positive results from a Phase II study evaluating XP19986, a prodrug of the... Read More
Recent Alert on 06/30/09 at 7:46am
XenoPort (XNPT) Reports Preliminary Results from Phase 2 Trial of XP19986
XenoPort (XNPT) Reports Preliminary Results from Phase 2 Trial of XP19986
View AllRecent Press Releases
Press Release on 06/30/09 at 6:30am
XenoPort Reports Positive Results from a Phase 2 Trial of Arbaclofen Placarbil in Spinal Cord Injury Patients with Spasticity
XenoPort Reports Positive Results from a Phase 2 Trial of Arbaclofen Placarbil in Spinal Cord Injury Patients with Spasticity
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 04/28/09 at 5:58am
FDA, Clinical Trial Updates: GTx, XenoPort and GlaxoSmithKline, Rockwell Medical
FDA, Clinical Trial Updates: GTx, XenoPort and GlaxoSmithKline, Rockwell Medical